Douglas JA - Search Results

1

History and molecular genetics of Lynch syndrome in family G: a century later.

Douglas JA, Gruber SB, Meister KA, Bonner J, Watson P, Krush AJ, Lynch HT. Douglas JA, et al. JAMA. 2005 Nov 2;294(17):2195-202. doi: 10.1001/jama.294.17.2195. JAMA. 2005. PMID: 16264161

2

Experimentally-derived haplotypes substantially increase the efficiency of linkage disequilibrium studies.

Douglas JA, Boehnke M, Gillanders E, Trent JM, Gruber SB. Douglas JA, et al. Nat Genet. 2001 Aug;28(4):361-4. doi: 10.1038/ng582. Nat Genet. 2001. PMID: 11443299

3

Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study.

Beebe-Dimmer JL, Wood DP Jr, Gruber SB, Douglas JA, Bonner JD, Mohai C, Zuhlke KA, Shepherd C, Cooney KA. Beebe-Dimmer JL, et al. Among authors: douglas ja. Urology. 2004 Feb;63(2):282-7. doi: 10.1016/j.urology.2003.09.036. Urology. 2004. PMID: 14972472

4

CDX2 polymorphisms, RNA expression, and risk of colorectal cancer.

Rozek LS, Lipkin SM, Fearon ER, Hanash S, Giordano TJ, Greenson JK, Kuick R, Misek DE, Taylor JM, Douglas JA, Rennert G, Gruber SB. Rozek LS, et al. Among authors: douglas ja. Cancer Res. 2005 Jul 1;65(13):5488-92. doi: 10.1158/0008-5472.CAN-04-3645. Cancer Res. 2005. PMID: 15994917

5

Identifying susceptibility genes for prostate cancer--a family-based association study of polymorphisms in CYP17, CYP19, CYP11A1, and LH-beta.

Douglas JA, Zuhlke KA, Beebe-Dimmer J, Levin AM, Gruber SB, Wood DP, Cooney KA. Douglas JA, et al. Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):2035-9. doi: 10.1158/1055-9965.EPI-05-0170. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16103457

6

Probability of detection of genotyping errors and mutations as inheritance inconsistencies in nuclear-family data.

Douglas JA, Skol AD, Boehnke M. Douglas JA, et al. Am J Hum Genet. 2002 Feb;70(2):487-95. doi: 10.1086/338919. Epub 2002 Jan 8. Am J Hum Genet. 2002. PMID: 11791214 Free PMC article.

7

Association between germline variation in the FHIT gene and prostate cancer in Caucasians and African Americans.

Levin AM, Ray AM, Zuhlke KA, Douglas JA, Cooney KA. Levin AM, et al. Among authors: douglas ja. Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1294-7. doi: 10.1158/1055-9965.EPI-06-1054. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17548701

8

Common variation in the BRCA1 gene and prostate cancer risk.

Douglas JA, Levin AM, Zuhlke KA, Ray AM, Johnson GR, Lange EM, Wood DP, Cooney KA. Douglas JA, et al. Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1510-6. doi: 10.1158/1055-9965.EPI-07-0137. Epub 2007 Jun 21. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17585057 Free PMC article.

9

Chromosome 17q12 variants contribute to risk of early-onset prostate cancer.

Levin AM, Machiela MJ, Zuhlke KA, Ray AM, Cooney KA, Douglas JA. Levin AM, et al. Among authors: douglas ja. Cancer Res. 2008 Aug 15;68(16):6492-5. doi: 10.1158/0008-5472.CAN-08-0348. Cancer Res. 2008. PMID: 18701471 Free PMC article.

10

Absence of CHEK2*1100delC mutation in families with hereditary breast cancer in North America.

Iniesta MD, Gorin MA, Chien LC, Thomas SM, Milliron KJ, Douglas JA, Merajver SD. Iniesta MD, et al. Among authors: douglas ja. Cancer Genet Cytogenet. 2010 Oct 15;202(2):136-40. doi: 10.1016/j.cancergencyto.2010.07.124. Cancer Genet Cytogenet. 2010. PMID: 20875877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters